Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium channels are integral membrane proteins that facilitate the selective transport of sodium ions across cell membranes, playing a fundamental role in cellular excitability and fluid homeostasis. This target entry encompasses two distinct protein families: voltage-gated sodium channels (VGSCs, Nav1.1–Nav1.9) and epithelial sodium channels (ENaC) (Catterall, 2012, J Physiol; Hanukoglu & Hanukoglu, 2016, Gene). VGSCs are essential for the initiation and propagation of action potentials in neurons and muscle cells, making them critical for nervous system function and cardiac rhythm (StatPearls, 2023, Physiology, Sodium Channels). ENaCs, conversely, are non-voltage-gated channels found in epithelial tissues like the kidney and lungs, where they mediate the rate-limiting step of sodium reabsorption (Hanukoglu & Hanukoglu, 2016, Gene). Dysregulation of VGSCs is linked to epilepsy, chronic pain, and arrhythmias, while ENaC mutations are associated with Liddle syndrome and pseudohypoaldosteronism (NIH, 2023, Liddle Syndrome). Pharmacological agents targeting VGSCs include local anesthetics, anticonvulsants, and Class I antiarrhythmics, whereas ENaC is primarily targeted by potassium-sparing diuretics such as amiloride (PubChem, 2024, Amiloride). Given their widespread physiological importance, therapeutic modulation of these channels requires high subtype selectivity to mitigate risks of cardiotoxicity, neurotoxicity, or severe electrolyte imbalances (StatPearls, 2023).
Voltage-gated sodium channel blockers inhibit the influx of sodium ions through the channel pore, preventing the depolarization phase of the action potential in excitable tissues (Catterall, 2012, J Physiol). Epithelial sodium channel blockers inhibit sodium reabsorption in the apical membrane of epithelial cells, primarily in the kidney, leading to increased sodium excretion and potassium retention (Hanukoglu & Hanukoglu, 2016, Gene).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium channel (Voltage-gated and epithelial) (Nav/ENaC).